-
Mashup Score: 0
A novel, once-daily, fixed-dose combination of mometasone furoate/indacaterol acetate/glycopyrronium bromide (MF/IND/GLY) delivered via Breezhaler® is the first inhaled corticosteroid/long-acting ꞵ2-agonist/long-acting muscarinic antagonist (ICS/LABA/LAMA) therapy approved for the maintenance treatment of asthma in adults inadequately controlled on ICS/LABA combination. In patients with asthma…
Source: Respiratory MedicineCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Treatments in patients with asthma | JAA - 1 year(s) ago
Once-daily (o.d.) formulations of MF/IND/GLY and MF/IND at different MF dose strengths
Source: www.dovepress.comCategories: Latest Headlines, PulmonologyTweet-
#Mometasone/ #Indacaterol/ #Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus #Fluticasone Propionate/ #Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ #Tiotropium in #Patients with #Asthma https://t.co/9p4beYJkg8 https://t.co/4RNrN9k1D0
-
-
Mashup Score: 2
One time a day, single-inhaler, high-dose MF/IND reduced asthma exacerbations and improved lung function versus two times a day, high-dose FLU/SAL in patients with inadequately controlled asthma. Similarly, improved outcomes were seen with one time a day, medium-dose MF/IND and two times a day, high …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet-
One time a day #mometasone/ #indacaterol fixed-dose combination versus two times a day #fluticasone/ #salmeterol in patients with inadequately controlled #asthma: pooled analysis from #PALLADIUM and #IRIDIUM studies https://t.co/Ghp60aTIKw https://t.co/4KdDmj90dI
-
-
Mashup Score: 1Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma - PubMed - 3 year(s) ago
Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
Source: PubMedCategories: Latest Headlines, PulmonologyTweet-
Lung Function Normalisation with #Indacaterol #Acetate/ #Glycopyrronium #Bromide/ #Mometasone #Furoate in Patients with #Asthma https://t.co/i0AoXQ5dbv https://t.co/rtZ86AoKtq
-
#Efficacy of once-daily, single-#inhaler, fixed- #dose combination of #mometasone/ #indacaterol/ #glycopyrronium in #patients with #asthma with or without persistent #airflow limitation: Post hoc #analysis from the IRIDIUM study https://t.co/lVuSNIUyha https://t.co/KnTfrLmZ2t